Publications by authors named "Todd L Saretsky"

Claim this Profile
P
Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer.
Niven Mehra, Emmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, Ray McDermott, Todd L Saretsky

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Outcomes in KEYNOTE-921: Pembrolizumab with Docetaxel and Prednisone for Patients with Metastatic Castration-resistant Prostate Cancer.
Nobuaki Matsubara, Daniel Petrylak, Raffaele Ratta, Ernesto Korbenfeld, Rustem Gafanov, Todd L Saretsky

Eur Urol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial.
Thomas Powles, Toni K Choueiri, Laurence Albiges, Katriina Peltola, Guillermo de Velasco, Todd L Saretsky

Lancet Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three Novel Patient-Reported Outcome Measures to Assess the Patient Experience With Daily and Weekly HIV Oral Antiretroviral Therapy.
Julie R Bailey, Eileen Fonseca, Alexander Borsa, Emily Hawryluk, Steven I Gubernick, Todd L Saretsky

J Acquir Immune Defic Syndr· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma.
Toni K Choueiri, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Stefan Symeonides, Todd L Saretsky

Oncologist· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric evaluation of the respiratory syncytial virus infection, intensity and impact questionnaire (RSV-iiiQ) in adults.
Valerie Williams, Carla DeMuro Romano, Lyn Finelli, Shanshan Qin, Todd L Saretsky

Health Qual Life Outcomes· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Outcome Measurement and Reporting for Patients with Advanced Renal Cell Carcinoma: A Systematic Literature Review.
Robert J Motzer, Pratik P Rane, Todd L Saretsky, Deepshikha Pawar, Allison Martin Nguyen

Eur Urol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring dengue illness intensity: Development and content validity of the dengue virus daily diary (DENV-DD).
Amy M Jones, Todd L Saretsky, Charlotte Panter, Jane R Wells, Frances White

J Patient Rep Outcomes· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the patient experience of respiratory syncytial virus infection: development of a patient-reported outcome measure.
Carla DeMuro Romano, Lyn Finelli, Sandy Lewis, Valerie Williams, Emily Martin, Todd L Saretsky

Health Qual Life Outcomes· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study.
Robert Motzer, Camillo Porta, Boris Alekseev, Sun Young Rha, Toni K Choueiri, Todd L Saretsky

Lancet Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma.
Pier Luigi Zinzani, Radhakrishnan Ramchandren, Armando Santoro, Ewa Paszkiewicz-Kozik, Robin Gasiorowski, Todd L Saretsky

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life (QoL) in patients with advanced melanoma receiving immunotherapies in real-world clinical practice settings.
Richard W Joseph, Frank Xiaoqing Liu, Alicia C Shillington, Cynthia P Macahilig, Scott J Diede, Todd L Saretsky

Qual Life Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence to Support Montgomery-Asberg Depression Rating Scale Administration Every 24 Hours to Assess Rapid Onset of Treatment Response.
Kristen M Johnson, Jacob M Devine, Kai Fai Ho, Kellee A Howard, Todd L Saretsky

J Clin Psychiatry· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis